Genscript Biotech Co. (OTCMKTS:GNNSF – Get Free Report) was the recipient of a significant decrease in short interest during the month of October. As of October 15th, there was short interest totalling 5,624,400 shares, a decrease of 11.9% from the September 30th total of 6,386,400 shares. Based on an average trading volume of 400 shares, the short-interest ratio is presently 14,061.0 days.
Genscript Biotech Stock Performance
Shares of OTCMKTS GNNSF remained flat at C$1.49 during midday trading on Thursday. Genscript Biotech has a 52-week low of C$1.05 and a 52-week high of C$3.20. The firm’s 50 day moving average price is C$1.44 and its 200 day moving average price is C$1.40.
Genscript Biotech Company Profile
Featured Articles
- Five stocks we like better than Genscript Biotech
- 3 Warren Buffett Stocks to Buy Now
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- Buy P&G Now, Before It Sets A New All-Time High
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- Health Care Stocks Explained: Why You Might Want to Invest
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for Genscript Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genscript Biotech and related companies with MarketBeat.com's FREE daily email newsletter.